Skip to main content
OpenTrials
Completed

NCT Number: NCT00472589

A Biological Sample Collection Protocol of Women With and Without Breast Cancer

The purpose of this trial is to collect plasma, serum, whole blood and tissue samples from women with breast cancer and plasma, serum, whole blood from healthy women, which will be made available to researchers for biomarker analysis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Medical & Surgical Specialists, LLC, Galesburg, Illinois, United States

Loading trial locations.

About this study

OUTLINE: This is a multi-center study.

The treatment plan for each breast cancer subject will be determined at the discretion of the treating physician and subject. This protocol does not prescribe any particular standard of care treatment.

There will be no treatment for the healthy volunteers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

FOR WOMEN WITH BREAST CANCER

  • Histologically or cytologically confirmed invasive malignancy or ductal carcinoma in situ of the breast.
  • Preparing to begin a new regimen for breast cancer (adjuvant, locally recurrent, any line metastatic).
  • Female.
  • Age > 18 years at the time of consent.
  • Written informed consent and HIPAA authorization for release of personal health information.

FOR HEALTHY VOLUNTEERS

  • No known history of invasive malignancy or ductal carcinoma in situ. Volunteers must not have prior history of malignancy in the past 5 years with the exception of basal cell and squamous cell carcinoma of the skin. Other cancers with low potential for metastasis, such as in situ cancers (e.g., Grade 1, TA TCC (low grade superficial bladder cancer), colonic polyp with focus of adenocarcinoma) can also be enrolled as healthy volunteers.
  • Female
  • Age > 18 years at the time of consent.
  • Written informed consent and HIPAA authorization for release of personal health information.

Exclusion criteria

  • Females must not be pregnant.

Sponsors and collaborators

Lead sponsor

Hoosier Cancer Research Network

Other

Collaborators

  • Indiana University
  • Purdue University

Registry information

Official study title

A Biological Sample Collection Protocol of Women With and Without Breast Cancer: Hoosier Oncology Group Study BRE06-120 for the Analytical Proteomics Team

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
May 11, 2007
Registry last updated
Aug 23, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.